OMGA Insider Trading Activity and SEC Form 4 Filings
OMGA insider trading summary
No open-market insider purchases or sales of Omega Therapeutics, Inc. (OMGA) have been reported on SEC Form 4 in the past 12 months.
Latest OMGA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 2, 2023 | Richard A Young | Director | Sell | $40K (5,000 @ $8.00) |
| May 1, 2023 | Richard A Young | Director | Sell | $40K (5,000 @ $8.00) |
| Apr 6, 2023 | Richard A Young | Director | Sell | $40K (5,000 @ $8.00) |
| Mar 17, 2023 | Richard A Young | Director | Sell | $80K (10,000 @ $8.00) |
| Feb 27, 2023 | Flagship Pioneering Inc. | 10% Owner | Buy | $11.5M (1,993,986 @ $5.78) |
| Feb 27, 2023 | Flagship Pioneering Special Opportunities Fund II General Partner LLC | 10% Owner | Buy | $11.5M (1,993,986 @ $5.78) |
| Feb 27, 2023 | Flagship Pioneering Inc. | 10% Owner | Buy | $7.7M (1,329,324 @ $5.78) |
| Feb 27, 2023 | Noubar Afeyan | Director | Buy | $11.5M (1,993,986 @ $5.78) |
| Feb 27, 2023 | Flagship Pioneering Special Opportunities Fund II, L.P. | 10% Owner | Buy | $11.5M (1,993,986 @ $5.78) |
| Feb 27, 2023 | Flagship Pioneering Special Opportunities Fund II General Partner LLC | 10% Owner | Buy | $7.7M (1,329,324 @ $5.78) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.